Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm IncfiledCriticalElan Pharm Inc
Publication of ECSP044940ApublicationCriticalpatent/ECSP044940A/en
Se presentan compuestos de la fórmula (I): útiles para tratar la enfermedad de Alzheimer y otras enfermedades similares. Estos compuestos incluyen inhibidores de la encima betasecretasa que son útiles para el tratamiento de la enfermedad de Alzheimer y otras enfermedades caracterizadas por la colocación de una peptida A beta en un mamífero. Los compuestos de la invención son útiles en composiciones farmacéuticas y métodos de tratamiento con el objeto de reducir la formación de la peptida A beta.Compounds of the formula (I) are presented: useful for treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the above betasecretase that are useful for the treatment of Alzheimer's disease and other diseases characterized by the placement of a peptide A beta in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment in order to reduce the formation of peptide A beta.
ECSP0449402001-07-112004-01-12
N- (3-AMINO-2-HIDROXIL-PROPIL) SUBSTITUTE COMPOUNDS OF ALQUILAMIDA
ECSP044940A
(en)